menu
    • menu

    Company profile for Cyclerion Therapeutics

    NEW Drugs in Dev: 6
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases. Cyclerion was founded with the goal of unlocking the full therapeutic potential of the nitric oxide-cyclic guanosine monophosphate (cGMP) signaling pathway. Imbalance in this pathway is linked to the pathophysiology...
    We are a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases. Cyclerion was founded with the goal of unlocking the full therapeutic potential of the nitric oxide-cyclic guanosine monophosphate (cGMP) signaling pathway. Imbalance in this pathway is linked to the pathophysiology of a wide range of cardiovascular, metabolic, inflammatory, fibrotic and neurological diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Cyclerion TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    301 Binney Street Cambridge, MA 02142
    Telephone
    Telephone
    857-327-8778
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.cyclerion.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/cyclerion
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/Cyclerion

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    SCOPE Summit

    SCOPE Summit

    Not Confirmed

    envelop Contact Supplier

    SCOPE Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cyclerion Therapeutics & Medsteer Agreement For Phase 2 CYC-126
    Cyclerion Therapeutics & Medsteer Agreement For Phase 2 CYC-126

    05 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/05/3213174/0/en/Cyclerion-Therapeutics-Announces-Strategic-Agreement-with-Medsteer-and-Progress-Toward-Initiating-Phase-2-Proof-of-Concept-Study-for-CYC-126-in-Treatment-Resistant-Depression.html

    GLOBENEWSWIRE
    05 Jan 2026
    Share Share
    Cyclerion Announces Relaunch as Neuropsychiatric Company
    Cyclerion Announces Relaunch as Neuropsychiatric Company

    23 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/23/3155076/0/en/Cyclerion-Announces-Transformational-Relaunch-as-a-Neuropsychiatric-Company.html

    GLOBENEWSWIRE
    23 Sep 2025
    Share Share
    Cyclerion’s sGC Stimulator Portfolio Drives Company Growth
    Cyclerion’s sGC Stimulator Portfolio Drives Company Growth

    17 Dec 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/12/17/2998240/0/en/Cyclerion-s-sGC-Stimulator-Portfolio-Generates-Revenues-to-Enable-Company-Growth.html

    GLOBENEWSWIRE
    17 Dec 2024
    Share Share
    Regina Graul, Ph.D., Promoted to Chief Executive Officer
    Regina Graul, Ph.D., Promoted to Chief Executive Officer

    07 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/07/2925801/0/en/Regina-Graul-Ph-D-Promoted-to-Chief-Executive-Officer.html

    GLOBENEWSWIRE
    07 Aug 2024
    Share Share
    Cyclerion Appoints Regina Graul, Ph.D., as President
    Cyclerion Appoints Regina Graul, Ph.D., as President

    04 Dec 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/12/04/2789962/0/en/Cyclerion-Appoints-Regina-Graul-Ph-D-as-President.html

    GLOBENEWSWIRE
    04 Dec 2023
    Share Share
    Cyclerion Strengthens Board of Directors
    Cyclerion Strengthens Board of Directors

    30 Nov 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/11/30/2789032/0/en/Cyclerion-Strengthens-Board-of-Directors-with-Experienced-Company-Builder-and-Cutting-edge-Innovator.html

    GLOBENEWSWIRE
    30 Nov 2023
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search